IOVA is poised for growth with Amtagvi's FDA approval for advanced melanoma and a 48.8% response rate, bolstered by a competitor's therapy rejection, enhancing its market dominance. Successful global expansion and positive pipeline trial outcomes could drive significant upside, with analysts raising price targets to $20.Iovance Biotherapeutics, Inc. stock forum
IOVA is poised for growth with Amtagvi's FDA approval for advanced melanoma and a 48.8% response rate, bolstered by a competitor's therapy rejection, enhancing its market dominance. Successful global expansion and positive pipeline trial outcomes could drive significant upside, with analysts raising price targets to $20.
IOVA so... is going to fall or is going to be pumped up more ?
IOVA - Iovance committed fraud. I will be filing a lawsuit against the company. I'm furious. I took my loss and I'm out. Best of Luck!IOVA - $110 all-time high...? The stock is extremely undervalued with the recent FDA approval of its skin cancer therapy which from what I've read cost $500k per treatment. - Strong BuyIOVA - Expanding operations/manufacturing = a spike in demand coming.European approval is coming.
The stock is dirt cheap.
philadelphia.today/2025/03/iovance-biotherapeutics-new-jobs/?s=09
IOVA 300,000 warrants is spewy for a company that is losing money and stock has been severely dilluted. The optics are as bad as the investment.
IOVA what next for IOVA? WHAT DO YOU THINK GUYS ? 🫶🏼
IOVA post earnings into 2025 20$ easy
IOVA I guess it’s a buyout.IOVA wow this looks Wild West here folks